Immuron is in the process of exploring non-dilutive funding opportunities for these Phase 3 clinical trials.
Immuron is in the process of exploring non-dilutive funding...
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.8M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 10.0¢ | $35.06K | 350.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 52502 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 222757 | 10 |
View Market Depth
| Last trade - 12.21pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
10.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 10.0¢ | 10.0¢ | 9.9¢ | 166996 | ||
| Last updated 13.09pm 06/05/2024 ? | |||||
| IMC (ASX) Chart |